upfront triplet therapy has os advantage in men with mcspc - medpage today
Published 3 years ago • 71 plays • Length 6:29Download video MP4
Download video MP3
Similar videos
-
1:52
better survival for african-americans with mcrpc - medpage today
-
2:23
astro: hormones radiation ups survival in prostate cancer
-
51:32
castration-resistant prostate cancer (crpc) guideline amendment
-
5:10
on-off therapy works in prostate cancer
-
1:41
the role of triplet therapy in men with metastatic castration sensitive prostate cancer
-
1:57
astro: radiation cuts mortality in advanced prostate cancer
-
3:09
aua: surgery works in locally advanced prostate cancer
-
3:53
stampede will 'change practice' in high-risk prostate cancer - medpage today
-
4:52
understanding metastatic hormone-sensitive prostate cancer (mhspc) with dr. fred saad
-
1:12:13
advanced #prostatecancer treatments | eugene kwon, md | diy combat manual | part 5 #pcri
-
9:54
systemic therapy options for "psa only" disease - 2021 prostate cancer patient conference
-
1:01:45
metastatic hormone sensitive prostate cancer: expert guidance for urologists
-
3:32
disease control with cabozantinib plus atezolizumab in crpc - medpage today
-
7:17
understanding metastatic castration-resistant prostate cancer
-
20:07
management of mhspc
-
2:04
astro: radiation blocks recurrence in high-risk melanoma
-
4:28
astro: proton radiation fails to impress in prostate cancer
-
1:39
surveillance of low-risk prostate cancer tripled - medpage today
-
44:02
treatment intensification for advanced prostate cancer
-
2:49
management of bcg failure in non-muscle invasive bladder cancer - medpage today
-
4:05
evaluating triplet therapy in metastatic hormone sensitive prostate cancer
-
17:34
mhspc: maximal androgen targeted vs chemohormonal therapy for mhspc